From August 29 to September 1, 1,250 delegates from across 79 countries and five continents attended the 5-Continent-Congress in Barcelona.
The Aesthetic Medicine Congress (TAMC), in association with the British College of Aesthetic Medicine, will take place in Dubrovnik on October 12 and 13.
The University of Salford has partnered with the ICE Postgraduate Dental Institute and Hospital to introduce a new PG Cert in Non-surgical Facial Aesthetics.
Global pharmaceutical company Allergan has received US Food and Drug Administration (FDA) approval for the use of Juvéderm VOLUMA XC with a TSK STERiGLIDE cannula for cheek augmentation to correct age-related volume definition in the mid-face in adults over 21.
A study has suggested that retrobulbar hyaluronidase injection is unlikely to alleviate vision loss caused by hyaluronic acid (HA) filler injections.
High street retailer Superdrug has announced that one in five of all patients treated in the last year on its Skin Renew Service featuring botulinum toxin and filler treatments have been male, with an average age of 45-49 years.
Aesthetic practitioner Dr Michael Aicken has released a statement confirming his support for training beauty therapists and other non-medical professionals in aesthetic injectables but Aesthetics Clinical Advisory Board members have disagreed with his views.
Liverpool-based aesthetic training provider Facethetics Training has launched a new Level 6 course for healthcare professionals (HCPs), accredited by Gatehouse Awards, which will appear on the Register of Regulated Qualifications, operated by Ofqual.
Plastic surgeon Mr Mauricio de Maio is unveiling two new dermal filler injection techniques to treat the chin and jawline, in conjunction with global pharmaceutical company Allergan.
The Joint Council for Cosmetic Practitioners (JCCP) has published new guidance for responsible prescribing for cosmetic practitioners.